Our previous studies demonstrated a significant and reciprocal correlation between YBX1 and ER in breast cancers [21, 26], and showed that the enhanced expression of YBX1 markedly downregulates the expression of ESR1 and induces acquired resistance to antiestrogen therapeutics [26]. Here, YBX1 is linked to breast cancer.